Kronos | KB-ENTO-3001

Clinical Trial Grant

Duke Scholars

Principal Investigator Harry Paul Erba Medicine, Hematologic Malignancies and Cellular Therapy

Awarded By

Kronos Bio, Inc

Start Date

January 14, 2022

End Date

February 14, 2024

Awarded By

Kronos Bio, Inc

Start Date

January 14, 2022

End Date

February 14, 2024